MCK Q2 2020 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q2 2020 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$57.6B+8.6% YoY

Gross Profit

$2.7B4.8% margin

Operating Income

$671M1.2% margin

Net Income

-$730M-1.3% margin

EPS (Diluted)

$-3.99

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

-$108M

Free Cash Flow

-$181M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$59.0B

Total Liabilities

$50.9B

Stockholders' Equity

$6.5B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57.6B	$53.1B	+8.6%
Gross Profit	$2.7B	$2.7B	+2.5%
Operating Income	$671M	$771M	-13.0%
Net Income	-$730M	$499M	-246.3%

Revenue Segments

U.S. Pharmaceutical Segment

$46.0B96%

Medical-Surgical Solutions Segment

$2.1B4%

Geographic Segments

UNITED STATES

$48.3B84%

International Segment

$9.3B16%